Page last updated: 2024-10-27

gentamicin and Eosinophilia-Myalgia Syndrome

gentamicin has been researched along with Eosinophilia-Myalgia Syndrome in 1 studies

Gentamicins: A complex of closely related aminoglycosides obtained from MICROMONOSPORA purpurea and related species. They are broad-spectrum antibiotics, but may cause ear and kidney damage. They act to inhibit PROTEIN BIOSYNTHESIS.

Eosinophilia-Myalgia Syndrome: A complex systemic syndrome with inflammatory and autoimmune components that affect the skin, fascia, muscle, nerve, blood vessels, lung, and heart. Diagnostic features generally include EOSINOPHILIA, myalgia severe enough to limit usual activities of daily living, and the absence of coexisting infectious, autoimmune or other conditions that may induce eosinophilia. Biopsy of affected tissue reveals a microangiopathy associated with diffuse inflammation involving connective tissue. (From Spitzer et al., J Rheumatol Suppl 1996 Oct;46:73-9; Blackburn WD, Semin Arthritis Rheum 1997 Jun;26(6):788-93)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Guharoy, SR1

Other Studies

1 other study available for gentamicin and Eosinophilia-Myalgia Syndrome

ArticleYear
Serum sickness secondary to ciprofloxacin use.
    Veterinary and human toxicology, 1994, Volume: 36, Issue:6

    Topics: Arthralgia; Cefazolin; Ciprofloxacin; Drug Hypersensitivity; Eosinophilia-Myalgia Syndrome; Female;

1994